Here are three things to know.
- The 12.5 milligram dose of the medication is being pulled off the market over failed dissolution specifications.
- Paroxetine is used to treat patients with depression, panic disorder and social anxiety disorder.
- The Food and Drug Administration labeled the recall as a Class III event, meaning the quality issue is not likely to cause adverse health risks to patients.
More articles on supply chain:
Herbal coffee recalled for containing erectile dysfunction drug ingredien
Puma Biotech earns FDA approval for breast cancer drug
A supply chain expert on what your performance dashboard is missing
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.